TTOOT2 Biosystems, Inc.

NAS · US · Healthcare · Diagnostics & Research · investors.t2biosystems.com

0.0006USD+20.00%Mkt Cap: 16827 $P/E: —4d ago

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel.…

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap16.83K $

Enterprise Value16.87M $

Revenue (TTM)7.68M $

Gross Profit-8.17M $

Net Income (TTM)-50.08M $

Revenue/Share0.7290 USD

Last Price0.0006 USD

Fiscal Year EndDec 2023

MR QuarterSep 2024

Employees113

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS89853L2034

Valuation

P/E (Trailing)—

P/E (Forward)-0.00

PEG—

EV/EBITDA-0.41

EV/Revenue2.20

P/S0.00

P/B-0.00

EPS (TTM)-0.02

EPS (Forward)-1.19

52W Range

0.00011% of range0.0800

52W High0.0800 USD

52W Low0.0001 USD

Profitability

Gross Margin-113.58%

Oper. Margin-511.89%

EBITDA Margin0.00%

Profit Margin-696.19%

ROE178.62%

ROA-143.91%

Growth

Revenue Growth34.90%

Earnings Growth—

Cash Flow & Leverage

Operating CF-48.14M $

CapEx (TTM)192.00K $

FCF Margin-343.45%

FCF Yield-156693.86%

Net Debt16.86M $

Net Debt/EBITDA-0.41

Balance Sheet

Debt/Equity-1.77

Current Ratio0.40

Quick Ratio0.17

Book Value/Sh-0.6240 USD

Cash/Share0.0990 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:100

Split DateOct 13, 2023

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.28.05M

Float11.90M

Insiders5.38%

Institutions0.00%

Short Interest

Short Ratio0.7d

Short % Float4.87%

Short % Out.3.02%

Shares Short846.14K

Short (prev mo.)942.49K

Technical

SMA 500.0007 (-10.2%)

SMA 2000.0032 (-81.3%)

Beta7.84

S&P 52W Chg18.16%

Avg Vol (30d)8.62K

Avg Vol (10d)7.51K

Technical Indicators

RSI (14)50.4

MACD-0.0001

MACD Signal-0.0001

MACD Hist.+0.0000

BB Upper0.0008 USD

BB Middle0.0005 USD

BB Lower0.0002 USD

BB Width126.69%

ATR (14)0.0003 USD

Vol Ratio (20d)1.37x